Teva Posts $590m Negative EBITDA Amid Opioid Deal And Write-Offs

Russian Invasion Of Ukraine Causes Massive Goodwill Impairment

 
• By Dean Rudge
  
Growth man drawing graph pen
Teva is looking to return to growth • Source: Christian Horz / Alamy Stock Photo
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business